Results 101 to 110 of about 13,238 (216)
Acute anaphylactic and multiorgan inflammatory effects of Comirnaty in pigs: evidence of spike protein mRNA transfection and paralleling inflammatory cytokine upregulation
British Journal of Pharmacology, Volume 183, Issue 20, Page 6225-6239, October 2026.Abstract Background and Purpose
Rare but severe adverse events (AEs) associated with mRNA‐lipid nanoparticle (LNP) COVID‐19 vaccines, such as Comirnaty, include anaphylaxis and inflammatory organ disorders, but their underlying mechanisms are poorly understood. We aimed to develop an animal model to study these phenomena.László Dézsi, Gábor Kökény, Gábor Szénási, Csaba Révész, Tamás Mészáros, Bálint A. Barta, Réka Facsko, Anna Szilasi, Tamás Bakos, Gergely T. Kozma, Attila B. Dobos, Béla Merkely, Tamás Radovits, János Szebeni +13 morewiley +1 more sourceEvaluation of the Reactogenicity, Safety and Immunogenicity of the Domestic Influenza Inactivated Split FLU-M Vaccine in Immunization Adults aged 18–60 Years [PDF]
, 2018 This article presents the results of a simple, blind, randomized, placebo-controlled, single-center, prospective research of the reactogenicity, safety, and immunogenicity of the domestic influenza inactivated split vaccine «Flu-M» in immunization of the S. Ya Melnikov, I. V. Fel'dblyum, S. O. Golodnova, V. P. Trukhin, S. D. Novgorodova, G. M. Ignat'ev +5 morecore +1 more sourceImage_2_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf
, 2023 IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.Thiago Dominguez Crespo Hirata (14435474), Leandro Yukio Mano Alves (17353003), Daniela M. Ferreira (7652402), Paola Martinez-Murillo (11478808), André G. Costa-Martins (5879597), Angela Huttner (408726), Helder I. Nakaya (7213244), Donata Medaglini (271513), Sara Sorgi (17353006), Ali M. Harandi (7431734), Eleonora Vianello (478990), Tom H. M. Ottenhoff (6906818), Claire-Anne Siegrist (146625), Ana Paula Barbosa do Nascimento (7141232), Isabelle Franco Moscardini (12894734), Mariëlle C. Haks (3169299), Patrícia Conceição Gonzalez Dias Carvalho (17353000), Francesco Santoro (2426011) +17 morecore +1 more sourceTable_5_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf
, 2023 IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.Thiago Dominguez Crespo Hirata (14435474), Leandro Yukio Mano Alves (17353003), Daniela M. Ferreira (7652402), Paola Martinez-Murillo (11478808), André G. Costa-Martins (5879597), Angela Huttner (408726), Helder I. Nakaya (7213244), Donata Medaglini (271513), Sara Sorgi (17353006), Ali M. Harandi (7431734), Eleonora Vianello (478990), Tom H. M. Ottenhoff (6906818), Claire-Anne Siegrist (146625), Ana Paula Barbosa do Nascimento (7141232), Isabelle Franco Moscardini (12894734), Mariëlle C. Haks (3169299), Patrícia Conceição Gonzalez Dias Carvalho (17353000), Francesco Santoro (2426011) +17 morecore +1 more sourceTable_3_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf
, 2023 IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.Thiago Dominguez Crespo Hirata (14435474), Leandro Yukio Mano Alves (17353003), Daniela M. Ferreira (7652402), Paola Martinez-Murillo (11478808), André G. Costa-Martins (5879597), Angela Huttner (408726), Helder I. Nakaya (7213244), Donata Medaglini (271513), Sara Sorgi (17353006), Ali M. Harandi (7431734), Eleonora Vianello (478990), Tom H. M. Ottenhoff (6906818), Claire-Anne Siegrist (146625), Ana Paula Barbosa do Nascimento (7141232), Isabelle Franco Moscardini (12894734), Mariëlle C. Haks (3169299), Patrícia Conceição Gonzalez Dias Carvalho (17353000), Francesco Santoro (2426011) +17 morecore +1 more sourceMaximum local reactogenicity, prime vs boost, by treatment group.
, 2018 Bar graphs show the percentage of participants in each treatment group reporting the specified maximum severity during the reactogenicity period. Left panels (Prime) indicate the maximum severity over all 3 priming injections.Magdalena E. Sobieszczyk (332353), M. Juliana McElrath (140060), Mary A. Allen (5774435), Shuying S. Li (262892), Gregory J. Wilson (2539195), David K. Clarke (5774447), Hong Van N. Tieu (5774438), Michael A. Egan (781415), Marnie L. Elizaga (102244), Ayuko Ota-Setlik (5774450), Theresa E. Latham (5774444), Ian Frank (10438), John H. Eldridge (781416), Nidhi K. Kochar (5774432), Brittany Sanchez (5774441), Christine Mhorag Hay (5774453), Drew Hannaman (221435), Kristen W. Cohen (106407), Rong Xu (296325) +18 morecore +1 more sourcePresentation_1_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf
, 2023 IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.Thiago Dominguez Crespo Hirata (14435474), Leandro Yukio Mano Alves (17353003), Daniela M. Ferreira (7652402), Paola Martinez-Murillo (11478808), André G. Costa-Martins (5879597), Angela Huttner (408726), Helder I. Nakaya (7213244), Donata Medaglini (271513), Sara Sorgi (17353006), Ali M. Harandi (7431734), Eleonora Vianello (478990), Tom H. M. Ottenhoff (6906818), Claire-Anne Siegrist (146625), Ana Paula Barbosa do Nascimento (7141232), Isabelle Franco Moscardini (12894734), Mariëlle C. Haks (3169299), Patrícia Conceição Gonzalez Dias Carvalho (17353000), Francesco Santoro (2426011) +17 morecore +1 more sourceImmunogenicity and safety of the adult tbe vaccine «tick-e-vac»
Вопросы вирусологии, 2017 About 3,000 cases of TBE are registered annually in the Russian Federation. Vaccination is the main way to prevent the tick-borne encephalitis disease.M. F. Vorovitch, G. B. Maikova, L. L. Chernokhaeva, V. V. Romanenko, A. V. Ankudinova, Yu. Kh. Khapchaev, G. G. Karganova, A. A. Ishmukhametov, S. G. Drozdov +8 moredoaj +1 more sourceImage_3_Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.pdf
, 2023 IntroductionThe rVSVDG-ZEBOV-GP (Ervebo®) vaccine is both immunogenic and protective against Ebola. However, the vaccine can cause a broad range of transient adverse reactions, from headache to arthritis.Thiago Dominguez Crespo Hirata (14435474), Leandro Yukio Mano Alves (17353003), Daniela M. Ferreira (7652402), Paola Martinez-Murillo (11478808), André G. Costa-Martins (5879597), Angela Huttner (408726), Helder I. Nakaya (7213244), Donata Medaglini (271513), Sara Sorgi (17353006), Ali M. Harandi (7431734), Eleonora Vianello (478990), Tom H. M. Ottenhoff (6906818), Claire-Anne Siegrist (146625), Ana Paula Barbosa do Nascimento (7141232), Isabelle Franco Moscardini (12894734), Mariëlle C. Haks (3169299), Patrícia Conceição Gonzalez Dias Carvalho (17353000), Francesco Santoro (2426011) +17 morecore +1 more source